Merck ends study of cholesterol drug
(AP) -- Merck & Co. has halted a study of an experimental drug it had touted as key to energizing its sagging cholesterol franchise, barely three weeks after U.S. regulators refused to allow sales of the drug.
Content from The Associated Press expires 15 days after original publication date. For more information about The Associated Press, please visit www.ap.org .
» Next Article in Medicine & Health - Medications: FDA stresses birth defect risks with Roche drug

Rating: n/a
Bookmark
Save as PDF
Print
Email
Blog It
Stumble It!


PhysOrg Forum
Video
Editorials
Free Magazines
Free White Papers
Newsletter
Advanced Search
Goto Archive
Suggest a story idea
Send feedback